Scarica l'app Stockscreener
0.7799
6.40%
-0.0533
Dopo l'orario di chiusura:
.78
0.000100
+0.01%
Precedente Chiudi:
$0.8332
Aprire:
$0.83
Volume 24 ore:
2.55M
Relative Volume:
1.05
Capitalizzazione di mercato:
$126.86M
Reddito:
-
Utile/perdita netta:
$-111.13M
Rapporto P/E:
-0.5908
EPS:
-1.32
Flusso di cassa netto:
$-91.53M
1 W Prestazione:
-8.95%
1M Prestazione:
+27.94%
6M Prestazione:
-30.98%
1 anno Prestazione:
-79.90%
Intervallo 1D:
$0.76
$0.8332
Intervallo di 1 settimana:
$0.76
$0.899
Portata 52W:
$0.36
$4.01
Tenaya Therapeutics Inc Stock (TNYA) Company Profile
Nome
Tenaya Therapeutics Inc
Settore
Industria
Telefono
415-865-2066
Indirizzo
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
Confronta TNYA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TNYA
Tenaya Therapeutics Inc
|
0.7799 | 135.53M | 0 | -111.13M | -91.53M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-10 | Iniziato | William Blair | Outperform |
| 2023-11-30 | Iniziato | Leerink Partners | Outperform |
| 2022-06-15 | Iniziato | H.C. Wainwright | Buy |
Tenaya Therapeutics Inc Borsa (TNYA) Ultime notizie
How Tenaya Therapeutics Inc. stock performs during market volatilityFree AI Screening for Swing Trade Picks - Newser
What analysts say about Tenaya Therapeutics Inc. stock outlookDaily Profit Watch With Forecast Confidence - Newser
How to read the order book for Tenaya Therapeutics Inc.Free AI Forecast for Trending Stocks - Newser
Will Tenaya Therapeutics Inc. stock go up soonGrowth Summary Based on Market Positioning - Newser
Is Tenaya Therapeutics Inc. forming a reversal patternInvestment Life Cycle Planning Summary - Newser
Analyzing net buyer seller activity in Tenaya Therapeutics Inc.Growth Summary Based on Market Positioning - Newser
What makes Tenaya Therapeutics Inc. stock price move sharplyAchieve triple-digit returns with smart investing - jammulinksnews.com
What are the latest earnings results for Tenaya Therapeutics Inc.Free Trend-Following Techniques - jammulinksnews.com
What is the dividend policy of Tenaya Therapeutics Inc. stockSuperior profit margins - jammulinksnews.com
What is Tenaya Therapeutics Inc. company’s growth strategyDiscover market opportunities with real-time data - jammulinksnews.com
Why Tenaya Therapeutics Inc. stock attracts strong analyst attentionAI Powered Stock Call - Newser
What institutions are buying Tenaya Therapeutics Inc. stock nowFree Stock Market Beginners Guide - Newser
Is Tenaya Therapeutics Inc. a Top Dividend Stock to Watch in 2025Consistent Win Signals - Newser
Intrinsic Value of Tenaya Therapeutics Inc. Stock: Is It Undervalued or OvervaluedCapital Growth Picks - Newser
Is Tenaya Therapeutics Inc. stock a growth or value playFree Investment Risk Control - jammulinksnews.com
What analysts say about Tenaya Therapeutics Inc. stockAccelerated investment success - PrintWeekIndia
What drives Tenaya Therapeutics Inc. stock pricePowerful profit generation - Autocar Professional
Tenaya Therapeutics Inc. Stock Analysis and ForecastRapid wealth multiplication - jammulinksnews.com
Is Tenaya Therapeutics Inc. a good long term investmentRapid profit acceleration - jammulinksnews.com
58,547 Shares in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Bought by Wealth Enhancement Advisory Services LLC - Defense World
Tenaya Therapeutics appoints new interim principal accounting officer - MSN
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Consensus Rating of “Buy” from Analysts - Defense World
Tenaya Therapeutics (NASDAQ:TNYA) Stock Price Down 0.3% – Here’s Why - Defense World
FDA clears Rocket Pharmaceuticals’ IND for gene therapy candidate - BioWorld MedTech
Tenaya Therapeutics, Inc.'s (NASDAQ:TNYA) market cap surged US$12m last week, private equity firms who have a lot riding on the company were rewarded - simplywall.st
Brokerages Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Price Target at $6.25 - Defense World
Millennium Management LLC Sells 174,447 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Tenaya Therapeutics (NASDAQ:TNYA) and Alpha Cognition (NASDAQ:ACOG) Critical Survey - Defense World
Squarepoint Ops LLC Decreases Stock Position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Nuveen Asset Management LLC Buys 69,377 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Deutsche Bank AG Acquires 97,318 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Northern Trust Corp Grows Stock Holdings in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Tenaya Therapeutics Inc Azioni (TNYA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.32%
1.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):